2A20

ICD-11 MMS 2026-01

Non mast cell myeloproliferative neoplasms

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Child codes

  • 2A20.0 – Chronic myelogenous leukaemia, BCR-ABL1-positive
  • 2A20.1 – Chronic neutrophilic leukaemia
  • 2A20.2 – Primary myelofibrosis
  • 2A20.3 – Chronic eosinophilic leukaemia, not elsewhere classified
  • 2A20.4 – Polycythaemia vera
  • 2A20.5 – Non mast cell myeloproliferative neoplasm, unclassifiable
  • 2A20.Y – Other specified non mast cell myeloproliferative neoplasms
  • 2A20.Z – Non mast cell myeloproliferative neoplasms, unspecified

Foundation children elsewhere

  • 3B63.1 – Acquired thrombocytosis

Sibling codes

  • 2A21 – Mastocytosis
  • 2A2Y – Other specified myeloproliferative neoplasm
  • 2A2Z – Myeloproliferative neoplasm, unspecified

Foundation entity

Non mast cell myeloproliferative neoplasms – http://id.who.int/icd/entity/1658448496

Allowed postcoordination axes

Part of: 02: Neoplasms